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Is it Just Amyloid Infiltration?*Claudio Rapezzi, MD,a Marianna Fontana, MD, PHDbC ardiac amyloidosis (CA) is a rare and pheno-typically heterogeneous disease, with path-ophysiological clinical and morphological
variability. From an imaging point of view, CA is
one of the cardiomyopathies with a hypertrophic
phenotype and is frequently misdiagnosed on echo-
cardiography as sarcomeric or idiopathic hypertro-
phic cardiomyopathy. However, there are
morphological and functional features that could un-
ravel the underlying myocardial infiltration, and rela-
tive apical sparing of longitudinal strain (LS)
impairment is among the most specific and almost
invariably reported findings.
Left ventricular (LV) apical sparing is a pattern of
regional differences in deformation in which LS in the
basal and middle segments of the left ventricle is
more severely impaired compared with the LS values
in the apical segments (1).
Apical sparing has been consistently observed in
the 2 main types of CA: light chain amyloidosis (AL)
and transthyretin amyloidosis (ATTR) (2). Although a
reduction in global LS is a common finding in any
myopathic process that impairs myocardial contrac-
tion, apical sparing, although not pathognomonic, is
highly specific for CA and has incremental diagnostic
(2) and prognostic (3) value over other echocardio-
graphic parameters traditionally used for this
purpose.ISSN 1936-878X/$36.00
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this paper to disclose.Despite the extensive published reports focusing
on apical sparing as a highly sensitive and specific
sign for CA and its relatively widespread clinical use,
the pathophysiological mechanism underlying apical
sparing is unclear. At least 3 main mechanisms can be
hypothesized: 1) less amyloid deposition at the apex
rather than the base; it is in fact possible that with
less amyloid deposition there is less resistance to
deformation and, through a process of dynamic reci-
procity, increased myocyte contraction, resulting in
relative sparing of apical LS; 2) the greater diversity of
myocyte and matric orientation at the apex compared
with the base; this could potentially have a role in
preservation of apical LS; and 3) greater tendency
toward apoptosis and remodeling in the basal seg-
ments related to turbulent flow in the LV outflow
tract and higher parietal stress.
The levels of evidence supporting these 3 hypoth-
esis are different. Although several publications have
reported a base-to-apex gradient in terms of amyloid
deposition (by using histology, cardiac magnetic
resonance [CMR], bone scintigraphy, and positron
emission tomography [PET]) (4–6), no studies are
available on the preferential involvement of specific
fiber subtypes or the higher degree of apoptosis and
remodeling at the base in CA.
In this context, one may question how the report by
Bravo et al. (7) in this issue of iJACC adds anything
other than incremental knowledge to the existing
published reports that focused on assessment of the
relationship between regional differences in LS and
amyloid burden. The answer lies in the rigorous
methodology, the multimodality approach, and the
well-characterized study group. Bravo et al. (7) stud-
ied 32 patients with AL amyloidosis with echocardi-
ography, to measure LS, and fluorine-18-florbetapir
PET and CMR, to measure the amyloid fraction (LV
florbetapir retention index [RI] and extracellularhttps://doi.org/10.1016/j.jcmg.2018.07.007
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1175volume [ECV], respectively). These investigators
found a significant base-to-apex gradient in LS,
maximal wall thickness, and LV mass. No statistically
significant differences were found in the amyloid
fraction (florbetapir RI determined by PET and ECV
determined by CMR), whereas markers of total amy-
loid load (total florbetapir binding and LV ECV) did
show a statistically significant base-to-apex gradient.
Bravo et al. (7) concluded that segmental differences
in the distribution of the total amyloid volume, rather
than the proportion of amyloid deposits, appear to
explain the marked regional differences in LS in CA.
The conclusion is in line with that of previous studies
because this report confirms the association between
regional differences in the distribution of amyloid
deposits and regional differences in LS. However, this
study adds a further nuance to this hypothesis by
focusing on the role of total amyloid volume, rather
than the proportion of amyloid, in determining apical
sparing.SEE PAGE 1165One immediately evident critique is that other
possible explanations for the regional differences in
LS were not explored in this study. The study focused
on the most extensively studied hypothesis (i.e.,
regional differences in amyloid load), thus leaving a
knowledge gap on the role of other mechanisms.
Although studying a greater tendency toward
remodeling and apoptosis would require a histologi-
cal approach, new CMR techniques have the potential
to shed light on the role of differential involvement of
specific fiber subtypes. The pixel-wise information
derived by ECV mapping combined with diffusion
tensor imaging could provide new insights into the
role of differential involvement of subgroups of fibers
with different orientation.
Moreover, only a subset of 22 patients underwent
CMR with ECV measurement. This is a crucial sub-
set within the report because the conclusion that
focused on the importance of total amyloid load,
rather than amyloid fraction, was made on the basis
of the lack of statistically significant differences
between the base and the apex in the florbetapir RI
measured with PET and the ECV measured with
CMR. There is a trend for a higher ECV at the base
compared with the apex, and the lack of statistical
significance in ECV could be related to the lower
number of patients assessed with CMR (one-third
less than those assessed with PET or echocardiog-
raphy). Furthermore, ECV measurement was used
(average across a region of interest), rather than
ECV mapping (pixel by pixel quantification of ECV),and this could contribute to less discriminatory
power for regional differences.
The work by Bravo et al. (7) is a cross-sectional
study. We do not know how apical sparing develops
with amyloid infiltration or whether it regresses when
there is cardiac amyloid regression. We also do not
know whether these patients were assessed before or
after chemotherapy or, in patients assessed after
chemotherapy, what the clonal response was. Recent
studies have shown that CA is a very dynamic pro-
cess, with clonal response being 1 of the most
important factors driving changes in cardiac infiltra-
tion. Amyloid regression is not an uncommon phe-
nomenon after successful suppression of the amyloid
precursor, and amyloid progression can develop
rapidly when there is no sufficient reduction in am-
yloid production (8). Studies assessing amyloid load
and LS serially will be needed to address this impor-
tant question.
Finally, only patients with AL amyloidosis were
included in the study. The findings therefore should
not be considered applicable to patients with ATTR
amyloidosis.
In summary, what we learned from this report by
Brave et al. (7) is that total amyloid burden seems
indeed to be related to the differences in LS. The total
amyloid volume was significantly higher at the base
compared with the apex, as shown by a proportion-
ally greater increase in LV mass that, in AL
amyloidosis, is mainly driven by amyloid infiltration
because there is no net gain in myocyte volume (9). It
is, however, possible that not only regional differ-
ences in amyloid load but also multiple mechanisms,
including the preferential involvement of specific fi-
ber subtypes or the higher degree of apoptosis and
remodeling at the base, form the pathophysiological
basis of apical sparing. It is also possible that each of
these mechanisms may be more or less prominent at
any time point (before, during, or after chemotherapy
in AL amyloidosis), depending on the individual pa-
tient (age, sex differences), the disease type (AL vs.
ATTR), and comorbidities (hypertension, aortic ste-
nosis). Apical sparing could therefore represent much
more than the consequence of regional features in
amyloid deposition, since it is probably the epiphe-
nomenon of complex interactions among infiltration,
anatomic structure, and myocardial adaptive and
maladaptive responses.
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